Skip to main content

Full Schedule

Full Schedule

  • Tuesday, March 21, 2023
  • 4:00 PM – 5:30 PM
    AMCP Talks: Incorporating Value Framework Assessments in Coverage and Reimbursement Decisions
  • Wednesday, March 22, 2023
  • 8:45 AM – 10:00 AM
    (2) Biosimilar Regulatory and Practical Considerations When Selecting Biosimilar Use in the Marketplace
  • 8:45 AM – 10:00 AM
    (3) AMCP Partner Session: Managed Care Perspective on HIV Prevention - A Public Health Priority
  • 8:45 AM – 10:00 AM
    (4) Prior Authorization Criteria: Looking Beyond Clinical Trial Populations
  • 8:45 AM – 10:00 AM
    (5) Impact of Accelerated Approval: Focus on Medications for Rare Diseases, Oncology, and Alzheimer's Disease
  • 8:45 AM – 10:00 AM
    (6) Evaluating the Evidence of Prescription Digital Therapeutics: A Panel Discussion
  • 10:30 AM – 11:45 AM
    (6) HEOR: What does it Mean to You?
  • 10:30 AM – 11:45 AM
    (7) IRON-ing Out the Details: Beta Thalassemia Landscape, Emerging Treatments, and Payer Considerations
  • 10:30 AM – 11:45 AM
    (8) Federal Legislative and Regulatory Update
  • 10:30 AM – 11:45 AM
    (9) Measuring Medical Cost Offsets from Improvements in Medication Adherence Using Real-World Data
  • 10:30 AM – 11:45 AM
    (10) Challenges and Opportunities in Collecting Data to Address Health Disparities
  • 3:15 PM – 4:30 PM
    Biosimilar Operational Readiness: Current and Future Market Landscape
  • 3:15 PM – 4:30 PM
    (6) Novel Therapies for Plaque Psoriasis: Aligning the Patient Perspective with Disease Management
  • 3:15 PM – 4:30 PM
    (7) AMCP Market Insights: Targeted Therapies to Deliver Improved Patient Outcomes in Oncology
  • 3:15 PM – 4:30 PM
    (8) Podium Session – Award-winning Research Supporting the Managed Care Pharmacy Research Agenda
  • 3:15 PM – 4:30 PM
    (9) The Role of Reinsurance and Stop-Loss Programs in Managing High-Investment Medications
  • Thursday, March 23, 2023
  • 8:00 AM – 9:15 AM
    (9) 2022-2023 Health Care and Pharmaceutical Marketplace Trends
  • 9:45 AM – 11:00 AM
    (10) Managed Care Approaches to Equitable Access to Recombinant Adeno-Associated Virus (rAAV) Gene Therapy
  • 9:45 AM – 11:00 AM
    (11) State Legislative and Regulatory Update
  • 9:45 AM – 11:00 AM
    (12) Drug Pipeline: Traditional Pharmaceuticals (Brands and Generics)
  • 9:45 AM – 11:00 AM
    (13) Disruptive Innovation in Pharmacy and the Impact on Managed Care
  • 9:45 AM – 11:00 AM
    (14) Cancer Drug Dose Rounding - Decreasing Drug Cost, Minimizing Waste and Improving Efficiency
  • 2:45 PM – 4:00 PM
    (13) Biosimilars in Vision: Addressing Drug Trends and Managed Care Strategies
  • 2:45 PM – 4:00 PM
    (14) Rare Disease Spotlight: Hemophilia Treatment Advances
  • 2:45 PM – 4:00 PM
    (15) Assessing & Overcoming Barriers to Real-time Benefit Check Adoption in the Real-World
  • 2:45 PM – 4:00 PM
    (16) Views on Value-Based Contracts: Aligning Payers and Manufacturers for Success
  • 2:45 PM – 4:00 PM
    (18) AMCP Partner Session: Covering and Operationalizing Prescription Digital Therapeutics
  • 4:30 PM – 5:45 PM
    (1) Biosimilar Operational Readiness: Managed Care Stakeholder Preparation for Market Expansion
  • 4:30 PM – 5:45 PM
    (2) AMCP Partner Session: Focus on Rare Diseases: Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
  • 4:30 PM – 5:45 PM
    (3) Alternative Payment Models: Real-World Examples from Managed Care Pharmacy
  • 4:30 PM – 5:45 PM
    (4) Addressing Racial Health Disparities: Focus on Medication Adherence
  • Friday, March 24, 2023
  • 9:45 AM – 11:00 AM
    (4) The Inflation Reduction Act: From the Outside Looking In
  • 11:15 AM – 12:30 PM
    (18) Specialty Pharmaceutical Pipeline 2023